Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements

Leukemia

Volumn 28, Issue 2, 2014, Pages 428-430

  De Lorenzo, P ^a   Moorman, A V ^b   Pieters, R ^c   Dreyer, Z E ^d   Heerema, N A ^e   Carroll, A J ^f   Hunger, S P ^g   Harvey, R ^h   Willman, C L ^h   Devidas, M ⁱ   Valsecchi, M G ^a   Harrison, C J ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMANS; INFANT; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 84893740353     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.280     Document Type: Letter

References (14)

1. Biondi A, Cimino G, Pieters R, Pui CH. Biological and therapeutic aspects of infant leukemia. Blood 2000; 96: 24-33.
2. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 1999; 17: 445-455.
3. Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood 2006; 108: 441-451.
4. Chessells JM, Harrison CJ, Watson SL, Vora AJ, Richards SM. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999. Br J Haematol 2002; 117: 306-314.
5. Frankel LS, Ochs J, Shuster JJ, Dubowy R, Bowman WP, Hockenberry-Eaton M et al. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). J PediatrHematol Oncol 1997; 19: 35-42.
6. Pieters R, Schrappe M, De Lorenzo P, Hann I, De RG, Felice M et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240-250.
7. Chessells JM, Harrison CJ, Kempski H, Webb DK, Wheatley K, Hann IM et al. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia 2002; 16: 776-784.
8. Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11)-a report of the Children's Cancer Group. Leukemia 1999; 13: 679-686.
9. Salzer WL, Jones TL, Devidas M, Hilden JM, Winick N, Hunger S et al. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407. Pediatric Blood Cancer 2012; 59: 834-839.
10. Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol 2010; 11: 429-438.
11. von Bergh AR, van DE, van Wering ER, van Zutven LJ, Hainmann I, Lonnerholm G et al. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes ChromosomesCancer 2006; 45: 731-739.
12. Heerema NA, Sather HN, Sensel MG, La MK, Hutchinson RJ, Nachman JB et al. Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia. Cancer 2002; 94: 1102-1110.
13. Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 2012; 119: 1872-1881.
14. Stam RW, Schneider P, de Lorenzo P, Valsecchi MG, den Boer ML, Pieters R. Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia. Blood 2007; 110: 2774-2775.